Literature DB >> 7929653

Attenuation of p53 expression protects against focal ischemic damage in transgenic mice.

R C Crumrine1, A L Thomas, P F Morgan.   

Abstract

Apoptosis or programmed cell death may be involved in neuronal death in the cerebral cortex after a permanent focal ischemic insult. Studies indicate that protein p53 is a major determinant of the cellular mechanism that leads to programmed cell death. Wild-type C57 mice and two groups of transgenic C57 mice, one homozygous and the other heterozygous for a p53 null gene, were subjected to middle cerebral artery occlusion. As expected, the wild-type mice had a large, consistent infarct volume (22.11 +/- 4.59 mm3; n = 10). Both transgenic groups had significantly less ischemic damage than the wild-type control group. However, unexpectedly, the heterozygous group had the least amount of ischemic damage (16.12 +/- 1.71 mm3, n = 11; 27% reduction in infarct size). The ischemic damage in the homozygous group (18.72 +/- 3.48 mm3, n = 9) was significantly less than in the wild-type control (15% reduction in infarct size) but significantly more than in the heterozygous group. Thus, although the absence of p53 expression was protective, greater protection was afforded by reduced expression of p53. These data suggest that attenuated p53 expression may be protective after an ischemic event.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929653     DOI: 10.1038/jcbfm.1994.119

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  53 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage.

Authors:  E J Morris; E Keramaris; H J Rideout; R S Slack; N J Dyson; L Stefanis; D S Park
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 3.  p53-mediated neuronal cell death in ischemic brain injury.

Authors:  Li-Zhi Hong; Xiao-Yuan Zhao; Hui-Ling Zhang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

4.  p53 opens the mitochondrial permeability transition pore to trigger necrosis.

Authors:  Angelina V Vaseva; Natalie D Marchenko; Kyungmin Ji; Stella E Tsirka; Sonja Holzmann; Ute M Moll
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

5.  Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin.

Authors:  Hiroko Tounai; Natsumi Hayakawa; Hiroyuki Kato; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2007-01-17       Impact factor: 3.584

6.  Interplay between Notch and p53 promotes neuronal cell death in ischemic stroke.

Authors:  Priyanka Balaganapathy; Sang-Ha Baik; Karthik Mallilankaraman; Christopher G Sobey; Dong-Gyu Jo; Thiruma V Arumugam
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

Review 7.  Neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Taku Sugawara; Miki Fujimura; Nobuo Noshita; Gyung Whan Kim; Atsushi Saito; Takeshi Hayashi; Purnima Narasimhan; Carolina M Maier; Pak H Chan
Journal:  NeuroRx       Date:  2004-01

8.  Bax involvement in p53-mediated neuronal cell death.

Authors:  H Xiang; Y Kinoshita; C M Knudson; S J Korsmeyer; P A Schwartzkroin; R S Morrison
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

9.  p53 Deficiency rescues neuronal apoptosis but not differentiation in DNA polymerase beta-deficient mice.

Authors:  Noriyuki Sugo; Naoko Niimi; Yasuaki Aratani; Keiko Takiguchi-Hayashi; Hideki Koyama
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury.

Authors:  Rehana K Leak; Lili Zhang; Yumin Luo; Peiying Li; Haiping Zhao; Xiangrong Liu; Feng Ling; Jianping Jia; Jun Chen; Xunming Ji
Journal:  Stroke       Date:  2013-02-21       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.